Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Geoerger

Showing results (41-50 of 179) with videos related to

Pageof 18
Sort By:
Pediatric Blood & Cancer|May 26, 2006
Do medulloblastoma tumors meet the Food and Drug Administration criteria for anti-erbB2 therapy with trastuzumab?Natacha Entz-Werle, Valérie Velasco, Agnès Neuville, et al.
Pediatric Blood & Cancer|December 2, 2017
Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphomaCharlotte Rigaud, Samuel Abbou, Véronique Minard-Colin, et al.
Pediatric Blood & Cancer|September 8, 2020
Precision medicine at its best: Prolonged survival in a child presenting a secondary mesothelioma treated with crizotinibAudrey Petit, Sylvie Lantuejoul, Anne Mc Leer, et al.
JCO Precision Oncology|January 11, 2024
Precision Medicine for Childhood Cancer: Current Limitations and Future PerspectivesMartin G McCabe, Birgit Geoerger, Louis Chesler, et al.
Frontiers in Oncology|December 12, 2019
A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of RhabdomyosarcomasSusanne A Gatz, Ewa Aladowicz, Michela Casanova, et al.
Haematologica|May 19, 2022
Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvementCharlotte Rigaud, Samuel Abbou, Stephane Ducassou, et al.
Cancer Medicine|February 24, 2018
Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG miceMaria Eugenia Marques da Costa, Estelle Daudigeos-Dubus, Anne Gomez-Brouchet, et al.
The Journal of Gene Medicine|January 15, 2005
Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastomaBirgit Geoerger, Victor W van Beusechem, Paule Opolon, et al.
Anti-Cancer Drugs|December 9, 2014
Inhibition of the NOTCH pathway using γ-secretase inhibitor RO4929097 has limited antitumor activity in established glial tumorsCarmela Dantas-Barbosa, Guillaume Bergthold, Estelle Daudigeos-Dubus, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: an Innovative Therapies for Children with Cancer (ITCC) studyBirgit Geoerger, Edward J Estlin, Isabelle Aerts, et al.
Pageof 18

Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
Pediatric Blood & Cancer|May 26, 2006
Do medulloblastoma tumors meet the Food and Drug Administration criteria for anti-erbB2 therapy with trastuzumab?Natacha Entz-Werle, Valérie Velasco, Agnès Neuville, et al.
Pediatric Blood & Cancer|December 2, 2017
Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphomaCharlotte Rigaud, Samuel Abbou, Véronique Minard-Colin, et al.
Pediatric Blood & Cancer|September 8, 2020
Precision medicine at its best: Prolonged survival in a child presenting a secondary mesothelioma treated with crizotinibAudrey Petit, Sylvie Lantuejoul, Anne Mc Leer, et al.
JCO Precision Oncology|January 11, 2024
Precision Medicine for Childhood Cancer: Current Limitations and Future PerspectivesMartin G McCabe, Birgit Geoerger, Louis Chesler, et al.
Frontiers in Oncology|December 12, 2019
A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of RhabdomyosarcomasSusanne A Gatz, Ewa Aladowicz, Michela Casanova, et al.
Haematologica|May 19, 2022
Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvementCharlotte Rigaud, Samuel Abbou, Stephane Ducassou, et al.
Cancer Medicine|February 24, 2018
Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG miceMaria Eugenia Marques da Costa, Estelle Daudigeos-Dubus, Anne Gomez-Brouchet, et al.
The Journal of Gene Medicine|January 15, 2005
Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastomaBirgit Geoerger, Victor W van Beusechem, Paule Opolon, et al.
Anti-Cancer Drugs|December 9, 2014
Inhibition of the NOTCH pathway using γ-secretase inhibitor RO4929097 has limited antitumor activity in established glial tumorsCarmela Dantas-Barbosa, Guillaume Bergthold, Estelle Daudigeos-Dubus, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: an Innovative Therapies for Children with Cancer (ITCC) studyBirgit Geoerger, Edward J Estlin, Isabelle Aerts, et al.
Pageof 18